Trial Profile
Study of Menactra [Meningococcal vaccine groups A C Y W-135 conjugate] in children aged 4-6 years when administered concomitantly with a fifth dose of DAPTACEL [DTaP vaccine].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; DTaP vaccine
- Indications Diphtheria; Meningococcal infections; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Sanofi
- 02 Mar 2010 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Actual patient number (882) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.